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Background: Medication regimes are often poorly adhered to, and the negative consequences of this are well
recognised. The dynamics underlying non-adherence are less understood. This paper examines adherence to
prescription medications for mental health difficulties in relation to the use of complementary and alternative medicines
(CAMs). This was based on suggestions that within medical pluralism, CAMs may reduce adherence to conventional
prescription medications for reasons such as their further complicating the medication regime or their being perceived
as a substitute with less adverse side effects than conventional prescription medications.
Methods: Data used was from the National Comorbidity Study Replication (NCS-R), specifically those 1396 individuals
who reported taking a prescription drug for mental health difficulties within the last 12 months and under the
supervision of a health professional. This subsample was selected due to their being the only subgroup questioned
regarding their medication adherence. Other demographic and health factors were also considered.
Results: The use of complementary medicines alongside the conventional medicines bore no significant relation to
odds of reporting adherence versus non adherence. Ethnicity and medication count were significant predictors of
adherence versus non-adherence.
Conclusions: The above findings are discussed from the point of both promoting the use of CAMs and increasing
health professionals’ understanding of the dynamics underlying adherence, or the lack thereof, and subsequently
informing interventions to reduce the problems associated with this issue in terms of increased health care needs and
reduced quality of life.
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Adherencea is “the extent to which a patient’s behavior
coincides with medical or prescribed health advice” [1].
It averages only 50% among patients suffering chronic
diseases (physical or mental) [2,3]. As a widespread
major obstacle to treatment effectiveness, patient quality
of life, and a burden and demand on the health care
system and the family, health professionals need to
understand and address the dynamics of adherence,
or the lack thereof [2]. This paper examines adherence
amongst those who reported taking a prescription drug
for mental health difficulties, and the extent to which
this relates to the use of complementary and alternative
medications.Correspondence: e.ennis@ulster.ac.uk
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reproduction in any medium, provided the orSeveral theoretical models have been applied to under-
standing medication adherence [4,5]. However, there
there is a large degree of concordance across the major-
ity of these theoretical models. They are primarily eco-
logically based, focusing on both social and cognitive
factors, and on factors spanning the illness and its
medication/treatment regime, the person/patient himself/
herself, and the interactions between the health care
provider and the patient [5-9]. This means that effective
interventions to increase adherence are individualized,
long-term, complex multilayered matters and many meet
with limited success [3,6-8,10]. Using relevant theoretical
frameworks to guide us towards an understanding of the
factors associated with adherence versus non adherence,
is essential to enhancing our understanding of the matter
and subsequently developing effective interventions to
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(both physical and mental) is the enduring popularity of
medical pluralism. Medical pluralism is “the use of more
than one medical system or the use of both conventional
and complementary and alternative (CAM) therapies”
[12]. CAM encompasses any healing practice that does
not fall within the realm of conventional medicine, but
these practices are referred to as complementary medi-
cine when used in conjunction with mainstream tech-
niques, or alternative medicine when used instead of it
[13]. Using the theoretical frameworks that have previously
been applied to understanding adherence, the present
study examines the proposition that medical pluralism in
the form of the use of complementary medicines may re-
late to non-adherence to conventional prescription medi-
cations for mental health difficulties [14].
Given the enduring popularity of medical pluralism
or the use of CAMs [12,15], the limited attention de-
voted to the relation between their use and adherence
to conventional prescription medications is somewhat
surprising [16]. For example, a review validating the
Information Motivation Strategy (IMS) model of adher-
ence does not discuss the possible role of CAMs at all
[6]. Similarly, a review of patient self-reported barriers to
adherence to antihypertensive medications using the
World Health Organization multidimensional adherence
model makes no mention of the possible importance of
CAMs or medical pluralism [5]. Various categories of
barriers are discussed in terms of health system barriers,
patient related barriers, therapy related barriers, socio-
economic related barriers and condition related barriers.
While many of these could be indirectly related to the
possible role of CAMs and medical pluralism, the article
in itself does not do this explicitly.
Existing evidence has been inconsistent about whether
CAMs use relates to adherence to prescription medical
regimes [7,9,14,16,17], or perceived effectiveness of con-
ventional medicines [14]. Discrepancies in findings may
be due to differences in the illness studied, the measure-
ment of adherence, the definition and form of CAM
employed, or even the sample or culture studied. To
contribute to overcoming this caveat, the current study
uses a large scale American random sample (NCSR) to
examine seeks to examine whether use of complemen-
tary and alternative medicines (CAMs) may relate to
non-adherence to conventional prescription medications
for mental health difficulties.
The primary reason suggested for a link between these
two domains has been the proposition that CAMs may
further complicate the medication regime and thus
reduce adherence to conventional prescription medi-
cations [9]. It is known that the more medications a
patient uses, the less likely the patient is to be adherent
to a medication regimen [9]. It has been suggested thatCAM use requires substantial time and energy, and may
be difficult for patients to incorporate into their day-to-
day life [16,17]. As a result, CAM users may feel logistic-
ally and/or psychologically overburdened and find it
necessary to sacrifice parts or their entire prescribed
treatment regimen to continue practicing CAM [16].
Thus, while some patients may use these alternative
medications as complementary to their conventional
prescription medications, some may use them as an alter-
native to their conventional prescription medications.
Secondly, it has been noted that for many illnesses, pa-
tients may often dislike taking conventional medications
due to unpleasant side effects [16]. This may increase the
likelihood that patients may discontinue taking their pre-
scribed medications and replace them with CAM therap-
ies which often have less frequent or less bothersome
side effects [16,18]. These issues as barriers to adherence
can easily be aligned with either the categories identified
by the World Health Organisation multidimensional ad-
herence model, or the IMS adherence model.
The current focus on the use of CAMs in relation to
adherence to conventional treatments of mental health
difficulties is also a welcome addition to current litera-
ture from the point of view that although interest in the
topic is increasing, relatively little research has examined
the use of CAM among adults with serious mental illnesses
(SMI) [14]. Although there has been some research con-
ducted amongst those experiencing serious mental illnesses
(SMI) e.g. bipolar sufferers [14], the majority of evidence
has been amongst those experiencing physical illnesses
such as hypertension [5,7], asthma [19], irritable bowel dis-
ease [20]. Non-adherence to medications for mental disor-
ders remains high [11,14], with rates being lower than
those documented in relation to physical illnesses [11].
This increased interest is due to the fact that rates of CAM
use among those experiencing mental illness are relatively
high [11,14]. This is possibly due to the historical difficul-
ties with conventional treatments for mental illness in
terms of the speed with which they show results suggesting
ineffectiveness for patients, and also continued distress due
to the persistence of symptoms of the mental illness and
also side effects of the medication, although side effects for
newer medications are slightly less intrusive than they were
for older medications [11,14]. Patients with psychiatric ill-
ness typically have great difficulty following a medication
regimen, but they also have the greatest potential for bene-
fiting from adherence [11].
Integration of treatment approaches is essential as
CAM therapies offer benefits when used appropriately
and are popular amongst lay people and health profes-
sionals alike [9,14,21]. Health professionals must under-
stand the relationship between CAMs and prescription
medication adherence [7]. Overall, the current study ex-
pands existing knowledge concerning personal adherence
Ennis BMC Complementary and Alternative Medicine 2014, 14:93 Page 3 of 9
http://www.biomedcentral.com/1472-6882/14/93to prescribed medications for mental health issues in terms
of how it relates to medical pluralism. This group of indi-
viduals (those taking prescription medications for mental
health difficulties) is focused upon as it was desirable
to use the NCSR due to it being a large scale random
representative sample, and within this dataset only
those taking prescription medication for mental health
difficulties are questioned concerning their adherence.
It is hypothesized that the use of CAMs may predict
adherence versus non adherence to prescription medica-
tions for mental health difficulties. In trying to understand
adherence, alongside CAMs, the role of demographics
such as sex, age, poverty index, education, ethnicity, mari-
tal status, and health factors such as health status and
medication count, psychiatric morbidity and chronic phys-
ical health will also be considered. These factors will be
incorporated into the analysis as they are personal and
health factors which have already been identified by the
World Health Organization (WHO) as influential within
adherence in general [2]. WHO outline some other fac-
tors may play a role within adherence [2], however the
aforementioned are those demographic and health fac-
tors for which information is available for within the
NCSR. “A better understanding of populations at greater
risk of non-adherence, and possible barriers to the
appropriate medication use, can offer targets for future
interventions” [22].
Method
The NCS-R assesses the prevalence and correlates of
mental disorders in a nationally representative sample of
the US [23]. A full report of the methods employed
within the NCS-R can be found at Kessler et al. [23]. The
Human Subjects Committees of both Harvard Medical
School (HMS) and the University of Michigan approved
the recruitment, consent, and field procedures of the
NCS-R [23]. These ethical guidelines are compliant with
the Helsinki Declaration on ethical principles for medical
research involving human subjects.
Samples
The overall NCS-R sample consisted of 9,282 individ-
uals. The subsample selected for analysis were those
who reported that in the last 12 months, they had taken
prescription drugs for mental health difficulties, with
this consumption being under the supervision of their
health professional (N = 1396). These were selected due
to their being the only subgroup questioned regarding
their medication adherence. An additional 144 individ-
uals reported also taking these same medications, but
not under the supervision of a health professional. This
subgroup was not included in analyses due to their lack
of medical supervision and their not being questioned
concerning adherence.The sample (the medication group) is 15% of the over-
all NCSR sample. Demographics are outlined in Table 1
and are taken from the screener section of the NCS-R,
namely sex, age, marital status, education, ethnicity and
poverty index. Many of the variables are already coded
within the dataset, but recoding of the information con-
cerning age, ethnicity and poverty index followed the
format of Kessler et al. [24].
Materials
Pharmacoepidemiology
Medication use and adherence were assessed within the
pharmacoepidemiology section of the NCS-R. Partici-
pants were asked two questions concerning their con-
sumption of prescription medicines in the past 12 months
for mental health difficulties. The first was a specific
question “In the past 12 months, did you take any of the
following types of prescription medications under the
supervision of a doctor, for your emotions or nerves or
your use of alcohol or drugs?”, which was followed by five
sets of specific examples (sleeping pills or other sedatives
(such as ambien or sonata); anti-depressant medications
(such as prozac or zoloft); tranquilizers (such as xanax or
ativan); amphetamines or other stimulants, (such as rit-
alin or dextroamphetamine); anti-psychotic medications,
(such as haldol or risperdal)), with participants being re-
quired to respond yes / no to each category. This was
followed by a more general question “Did you take any
type of prescription medicine in the past 12 months for
problems with your emotions, substance use, energy,
concentration, sleep, or ability to cope with stress?”, with
participants again responding yes / no. Participants who
indicated a yes answer to any of the above questions were
subsequently asked whether this medication consump-
tion was under the supervision of their health profes-
sional. Only those who indicated that their medication
consumption was under the supervision of a health pro-
fessional (N = 1396) were examined in the current study,
as only these were interviewed in detail concerning ad-
herence to their medicationsb Whilst this was the general
criteria for inclusion within the sample, within the binary
logistic regression analysis, these six categories of drug
type considered separately.
Specifically, “People do not always take their medica-
tion as they are supposed to. Think of a typical month
when you took (med) in the past 12 months. How many
days out of 30 did you typically either forget to take it or
take less of it than you were supposed to take?” Partici-
pants were asked about their adherence to three medica-
tions. However, Pearson’s correlation coefficient showed
a strong correlation coefficient between the measures
of adherence to each of the three medications (r = 51,
r = .52, r = .72, all p < .001). Although there is slight vari-
ation in the strength of these correlation coefficients, all
Table 1 Logistic regression using sample characteristics, health profile and complementary medicines as predictors of
adherence versus non adherence
N B Wald Chi-square odds ratio 95% CI for odds ratio
Lower Upper
Use of CAMs (ref = none) 660 1.66
Only non-pharmacological CAMs 225 -.05 .05 .95 .64 1.43
Only herbal remedies / supplements 34 .56 1.45 1.75 .70 4.35
Both non-pharmacological and herbal remedies / supplements 103 -.06 .05 .94 .53 1.65
Drug type (ref = sleeping pills/sedatives) 80 8.01
Anti-depressant medications 431 .19 .41 1.21 .68 2.15
Tranquilizers 60 -.31 .52 .73 .31 1.71
Amphetamines or other stimulants 5 .38 .11 1.47 .16 13.61
Anti-psychotic medications 10 -.40 .20 .67 .11 3.91
Other mental health medicine 79 -.65 2.58 .52 .24 1.15
Multiple medication types 357 -.07 .05 .93 .51 1.70
Chronic physical health conditions (ref = absent (N = 88) v present) 934 .10 .12 1.11 .62 1.98
Psychiatric morbidity (ref = no disorders) 298 1.60
1 disorder 209 -.25 1.16 .77 .49 1.23
2 disorders 158 .06 .05 1.06 .64 1.77
3 or more disorders 357 -.08 .14 .92 .59 1.44
Medication count -.06 4.59* .94 .88 .99
Sex (ref = male (N = 296) v female 726 -.01 .00 .99 .70 1.40
Age 18-29 years (ref) 148 4.76
30-44 years 327 -.01 .00 .99 .56 1.73
45-59 years 345 .00 .00 .99 .55 1.79
60 years plus 202 -.52 2.12 .60 .30 1.20
Ethnicity (ref = non-hispanic white) 858 6.60
Non-hispanic black 72 .48 1.93 1.62 .82 3.21
Hispanic 57 .73 4.87* 2.07 1.08 3.94
Other 35 .34 .43 1.40 .51 3.83
Marital status (ref = married or cohabiting 524 1.80
Previously married 316 -.12 .36 .89 .60 1.31
Never married 182 .25 .99 1.29 .78 2.11
Family income (ref = low) 245 .97
Low average 278 .19 .63 1.21 .76 1.93
High average 288 .01 .01 1.01 .62 1.65
High 211 .13 .23 1.14 .67 1.95
Education 0–11 years (ref) 161 .18
12 years education 280 .04 .02 1.04 .63 1.72
13-15 years education 329 -.04 .02 .96 .56 1.63
16 or more years education 252 -.05 .03 .95 .54 1.69
Key; *p < .05; ref = reference group.
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gesting that non-adherence to one medication was accom-
panied by similar degrees of non-adherence to other
medications, and thus only the first measure of adherencewill be used as an overall measure of adherence. All indi-
viduals within this subgroup had an adherence score,
which could range between 0 and 30 depending on the
number of days within the month that they reported
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indicated perfect adherence. All other scores (i.e. not taking
the medication anything between 1 and 30 days) were
regarded as non-adherence. The question on medication
count was also taken from this pharmacoepidemiology
section.
Complementary and alternative medicines (CAMS)
Within the services section of the NCSR, respondents
were given a list of commonly used alternative therapies
and asked “Did you use any of these therapies in the past
12 months for problems with your emotions or nerves
or your use of alcohol or drugs?” For the purposes of the
present study, the list of specified therapies were coded
as non-pharmacological CAMS (e.g. acupuncture, bio-
feedback, chiropractic, energy healing, exercise or move-
ment therapy, hypnosis, imagery techniques, massage
therapy, relaxation or meditation techniques, self-help
and internet support groups, spiritual healing by others)
and herbal remedies/supplements (herbal therapy (e.g.,
St. John’s Wort, chamomile), high dose mega-vitamins,
homeopathy, special diets). CAM use was measured fol-
lowing the methodology of Woodward, Bullard, Taylor,
Chatters, Baser and Perron [25]. Accordingly, “prayer or
other spiritual practices” was not included in the CAM
group [25]. The NCSR did include a question on the use
of CAMs other than those on the list. This question was
omitted from the current analyses as it would not be
possible to determine whether it was herbal remedies/
supplements or non-pharmacological.
Mental disorder status
Mental disorder status was assessed by a structured
interview, namely the WHO Composite International
Diagnostic Interview (WMH-CIDI) [26]. DSM-IV disor-
ders were examined following the format of the principal
leader of the World Mental Health project, of which the
NCS-R is a component [24]. Disorders considered were
those outlined by Kessler [24], and included diagnoses
from the domains of mood disorders, anxiety disorders,
impulse control disorders and substance disorders [24].
The criteria of Kessler [24] were also used to consider
the matter of psychiatric morbidity in that individuals
were grouped as to whether they had no disorder, one
disorder, two disorders, or three or more disorders [24].
Chronic conditions of physical health
Within the chronic conditions of the NCSR, participants
were asked whether or not they had ever had arthritis or
rheumatism, chronic back or neck problems, frequent or
severe headaches, any other chronic pain, seasonal aller-
gies like hay fever, a stroke, heart attack, heart disease,
high blood pressure, asthma, tuberculosis, chronic lung
disease like COPD or emphysema, diabetes or highblood sugar, ulcer in the stomach or intestine, HIV infec-
tion or AIDS, epilepsy or seizures, or cancer. Participants
were coded in terms of whether or not they indicated
that they had any of these conditions. It was not possible
to determine whether the participant still had or still re-
ceived any treatment for their chronic condition as this
information was not obtained for all illnesses.
Analyses
The specified hypothesis was examined using binary
logistic regression. The minimum level for statistical
significance was .05 within all analyses. As data is based
on part 1 and part 2 variables, for the binary logistic re-
gression analysis, data was weighted based on weight 2
within the NCSR data set [23]. Frequencies reported
within Table 1 are those which SPSS included in the
analysis after weighting.
Results
Of those who reported taking prescription medications
for mental health difficulties under the supervision of a
health professional (N = 1396), 710 individuals (50.9%)
reported perfect adherence (missing their medications
on 0 days per month), 496 individuals (35.5%) reported
non adherence (missing their medications on anything
between 1 and 30 days per month) and adherence infor-
mation was missing for 190 individuals (13.6%). Binary
logistic regression assessed the hypothesis. Adherence
versus non adherence to the prescription medications
for mental health difficulties was the outcome variable.
The use and type of complementary medications, ele-
ments of personal health profile (drug type, medication
count, the absence versus presence of a chronic physical
health condition, and psychiatric morbidity) were used
as predictors, as were sample demographics (age, sex,
ethnicity, marital status, education, and poverty index).
A test of the full model with all 11 predictors against a
constant only model was not statistically significant (χ2
(29, N = 1022) = 41.22, p > .05), indicating that that pre-
dictors do not make a significant contribution to the
prediction of adherence versus non-adherence. However,
classification was unimpressive with a success rate of
64%, which is practically identical to the 63% classifica-
tion rate indicated based on block zero of the model (i.e.
the chances of correctly predicting whether an individual
was adherence or non-adherent if we knew nothing
about the predictor variables). In order to consider the
rate of classification as impressive, the accuracy rate of
classification of the model including the predictor vari-
ables would need to be a substantial improvement on
the classification ability of the model without predictors.
Similarly, Nagelkerke R2 yielded a value of .08, indicating
that the combined predictors only explained 8% of the
variance in adherence / non-adherence.
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the hypothesis. CAMs (use or type), drug type, chronic
physical health conditions (absence versus presence),
psychiatric morbidity, nor medication count, signifi-
cantly predicted the odds of reporting non-adherence
versus adherence (Table 1). Sex, age, marital status, pov-
erty index, and education were also non-significant pre-
dictors of non-adherence versus adherence (Table 1).
Ethnicity was related to medication adherence in that in
comparison with those who identified themselves non-
Hispanic white background, those of Hispanic back-
ground were twice as likely to report non adherence
(Table 1). The only other significant predictor was medi-
cation count in that as ones medication count increased,
the likelihood of reporting adherence decreased and
the likelihood of reporting non adherence increased
(Table 1). This was partially supportive of the initial
hypothesis.
Discussion
The current results agree with the prevalence of non-
adherence to conventional prescription medications
[2,3], even when these are being taken under the super-
vision of a health professional. Results were partially
supportive of hypothesis one in that only ethnicity and
medication count were significant predictors of adher-
ence versus non adherence to conventional prescription
medications for mental health difficulties. Health factors
such as drug type, psychiatric morbidity, absence versus
presence of a chronic physical health condition, and
demographic factors such as sex, age, poverty index,
education and marital status, bore no relation to the pre-
diction of adherence versus non adherence. Further-
more, similar to some studies [9,14], the current results
show no relation between the use of CAMs and adherence
to prescription conventional medications. This was regard-
less of the type of CAM used (non-pharmacological treat-
ments or herbal remedies / supplements).
This is noteworthy given the enduring popularity of
medical pluralism or the use of CAMs [12,15]. This find-
ing contributes to allaying fears that the potential bene-
fits of integrating CAMs may be undermined by their
reducing adherence to conventional prescription medi-
cations. Integration of treatment approaches is essential
as CAM therapies offer benefits when used appropriately
and are popular amongst lay people and health profes-
sionals alike [9,14]. This current results provide some
evidence to refute the suggestion that patients using
CAM may be doing so as an alternative to conventional
medicine as opposed to complementing treatment regi-
mens [16]. It must however still be acknowledged that
these findings are in contrast to others which have
shown use of CAM to be associated with reduced adher-
ence to conventional prescription medications [9,16,17].Further in-depth research is necessary in terms of actu-
ally interviewing people, and possibly considering differ-
ent illnesses (across both the physical and mental sector)
independently.
Care must also be exercised in view of the fact that al-
though CAM was not related to adherence versus non
adherence, in agreement with earlier research [9], in-
creased medication count was a significant predictor of
non-adherence. Health professionals must be mindful to
keep patients medication regime as uncomplicated as
possible. Health professionals should also question pa-
tients regarding any complementary therapies that they
use and ensure that the patient has a plan as to how
both regimes can be effectively integrated into their life
style as opposed to the burden of one domain resulting
in the sacrificing of the other domain [16]. This is neces-
sary as many patients do not tell their physicians and
thus explicit dialogues is necessary as provider aware-
ness of their patient’s use of CAM therapies may be
important to ensuring that patient preferences are recog-
nized to help ensure continued engagement in conven-
tional treatment [9,14]. Such explicit conversations are
also necessary to avoid situations such as drug–drug in-
teractions, drug substitutions with CAM, and treatment
noncompliance, particularly among persons with serious
mental illnesses [14]. Further research on this domain is
necessary given that although increased medication count
was associated with non-adherence, the use of herbal
remedies / supplements was not directly related to non-
adherence to conventional prescription medications.
Based on their suggested importance [2], demographic
factors (sex, age, education, ethnicity, marital status and
poverty index) as well as elements of personal health
(drug type, medication count, psychiatric morbidity, and
absence versus presence of a chronic physical illness)
were included in the model. Findings regarding medica-
tion count have already been discussed. The lack of
association between physical health and adherence to
conventional medications could be said to be somewhat
curious. It is possibly because the data does not examine
the degree of the health problem and the impact on the
activities of daily living. It does not allow distinction
between acute illness and chronic illness, or even con-
sideration of whether the illness is being effectively con-
trolled by medication or even in remission. It could
be tentatively suggested that with severe acute phys-
ical health problems, the likelihood of adherence may
go up. With chronic problems, adherence may possibly
go down.
Medication adherence was unrelated to sex, age, edu-
cation, marital status or poverty index. However, find-
ings suggested that ethnicity was related to medication
adherence in that in comparison with those who identi-
fied themselves non-Hispanic white background, those
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non adherence. Presence versus absence of a chronic
physical illness bore no significant relation to non-
adherence. BMI was not included as a marker of phys-
ical health. This was because in the realm of mental
health problem, whilst appearing unhealthy, an increased
BMI could be associated with adherence to psychotropic
medication. Many (but not all) of these are associated
with weight gain.
Limitations
Medication adherence was unrelated to psychiatric mor-
bidity. Psychiatric morbidity did not appear to com-
promise their ability to manage personal medications.
However, a limitation must be acknowledged in that
within each category, the range of severity is potentially
large. For instance, an affective disorder may manifest it-
self as a mild depressive episode at one end of the
spectrum and as a bipolar I disorder at the other. Sever-
ity is accounted for to some degree by controlling for
clinical diagnosis. Whilst useful and informative, the
current data format may not show the entire picture and
further in-depth study may be required. Medication
count may constitute a marker for severity of illness or
an expression of conventional medicines not working,
however this proposition could not be tested. Kessler
et al. [24] outline criteria under which clinical disorders
may be coded as mild, moderate or severe [24]. How-
ever, the algorithms necessary to do this are only avail-
able to the World Mental Health (WMH) team.
It is also noteworthy that there were individuals who
were taking a medication for a mental health difficulty
under the supervision of a health professional, yet
did not meet neither the DSM nor the ICD criteria
for the presence of any mental health difficulty (mood
disorder, anxiety disorder, substance disorder, nor im-
pulse disorder). The question had asked whether they had
taken a prescription drug for problems with their emo-
tions, nerves, their use of alcohol or drugs energy, concen-
tration, sleep, or ability to cope with stress, with this
consumption being under the supervision of their health
professional. Whether they have a DSM or ICD diagnosis
outside the four mentioned categories warrants attention.
In particular, the unique issues of psychosis require
consideration. This matter was somewhat problematic
within the current dataset. Although anti-psychotics
were amongst the list of specified medications, informa-
tion concerning diagnosis of psychosis is somewhat
vague. For the mental health difficulties considered in
this paper, participants were asked a large range of ques-
tions and these responses were evaluated by trained re-
searchers against the DSM and ICD criteria. However,
with regard to psychosis, individuals were asked whether
or not they had ever had a series of experiences, if theyhad consulted their health professional concerning this,
and if so, what had diagnosis had their health profes-
sional applied. This is obviously reliant on the accuracy
of the participants memory, and given the difference in
this and how the diagnosis of the other mental health
difficulties was applied, the current paper considered the
information available insufficient to actually apply a
diagnosis of psychosis.
The current study simply provides a one point in time
picture. The data assessed adherence to supervised med-
ications for mental health difficulties, and whether this is
comparable to adherence for physical health difficulties
is unknown. Some evidence suggests that interview
based self-reports of medication adherence are not con-
cordant with electronic measures of actual adherence
[27]. However, such measures have been used in scientific
research in peer reviewed academic journals and have
received positive evaluations within reviews where the
conclusion has been that no one method should be con-
sidered as the “gold standard” [11].
The current data focuses on people who self-reported
taking medication. For future research, it could be said
to be important to include people who were offered
medication but declined to accept it as it could be sug-
gested that this is the ultimate example of non-adherence.
Other important issues to consider may include ethnicity,
family relations, as well as severity and chronicity of mental
health problems. With regard to the NCSR, the matter of
chronicity of illness is complicated. For each mental illness,
timing of first episode is often (although not always) asked
of the participant. However, there may be confusion con-
cerning first clinical episode versus first appearance of
milder subclinical symptoms.
Conclusions
Further in-depth research on the practical applications
of these findings and the additional influential factors is
needed given the small proportions of variance ex-
plained, and the lack of an increase in correct classifica-
tion. It is extremely concerning that non adherence to
prescription medications for mental health difficulties is
such an extensive problem, and even though a vast array
of factors were considered in the current analysis, it was
not possible to explain a significant proportion of the
variance in adherence versus non-adherence. This could
be considered as a warning of just how complex the
issue is, and the difficulty that health professionals face
in trying to understand the matter. The possibility must
also be considered that that factors explaining adherence
to medications for pure physical health difficulties may
differ somewhat from those factors which explain adher-
ence to medications for mental health difficulties.
To conclude, poor medication adherence is an exten-
sive problem [2,3] which needs examined in terms of
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and perceptions) [5-9]. A matter of concern is that des-
pite the breadth of the factors included in the current
analysis, it was not possible to significantly explain the
variance in adherence versus non-adherence. Vulnerabil-
ity factors to non-adherence may include ethnicity and
increased medication count. Further research is neces-
sary, but the current findings suggest that efforts to
understand the dynamics underlying non adherence to
conventional prescription medications should move
away from studying the domain of use of CAMs. Factors
for health professionals and researchers to consider in
the future may include the domains of family burden
and caregiver role. Evidence from some small studies
suggests that in their endeavor to provide effective care
for their care recipient, caregivers may actually com-
promise their own self-care [28]. “A better understand-
ing of populations at greater risk of non-adherence, and
possible barriers to the appropriate medication use, can
offer targets for future interventions” [23]. However
health profession councils also need to support health
care providers in designing and delivering patient tar-
geted interventions [29]. Many health providers need
help to work on their accepting their pivotal responsi-
bility for promoting adherence and believing that they
influence it, with only a minority routinely assessing
adherence in the recommended manner [7,29]. Many
health professionals lack training and confidence on
how to effectively assess this within a consultation, fear-
ing intrusion of privacy or appearing as challenging the
patient [29].Endnotes
aThe current paper consciously uses the term ‘adherence’
rather than ‘compliance’ in recognition of the importance
of the interaction between the health professional and the
layperson.
bIt is acknowledged that these “three medications”
may be different for different people and adherence to
medication may vary as function of whether the medica-
tion is perceived as important or providing them with
relief from complaints as opposed to limiting future
risks for health outcomes. However, all medications re-
ported in this section would be for the treatment of
mental health difficulties as opposed to physical health
difficulties (although their function may be to address a
physical issue that is a secondary symptom of a primary
mental health difficulty.
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